Pharma Stat Sci Company Profile

21:07 EDT 18th March 2018 | BioPortfolio

Welcome to Pharma Stat Sci, a work-in-progress. The purpose of this web is to provide information on leading pharmaceutical R&D data analysis technologies and methods.
We will be providing a number of resources here to help you learn new technologies, exchange ideas and computer programs, post relevant meetings, workshops, and training courses, discuss special topics in science and technology, and whatever else the user community suggests.

Current Status - In development, and seeking preliminary feedback and contributions.



News Articles [1250 Associated News Articles listed on BioPortfolio]

A “stat” palliative care consult: cognitive dissonance meets cognitive ignorance

It was a perfectly comfortable morning when suddenly it was discomforted by a request for a stat palliative care consult. A stat consult is disquieting because “stat” is a dissonant adject...

STAT Plus: A sneak peek at the 2017 STAT Wunderkinds

For STAT Plus subscribers, here's a sneak peek at the 2017 STAT Wunderkinds — young scientists and doctors blazing new trails in biomedical research.

#news #biotech Amid harassment reports from STAT, Orbimed’s Sam Isaly suddenly departs

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Amid harassment reports from STAT, Orbimed’s Sam Isaly suddenly departs...

STAT Plus: 3 pharma trends to watch in 2018

Pharma's perpetual race for profits and reliance on the U.S. as its biggest customer are certain to cause tensions in 2018 as Americans struggle with pocketbook anxiety over high drug…

STAT Plus: With an arthritis drug no better than common saline, Ampio Pharma’s shot at FDA approval is dim

In recent weeks, Ampio CEO Michael Macaluso has also told investors the company is garnering takeover interest from multiple pharma companies. This, too, will not happen.

Lowering the bar on Alzheimer’s drugs: STAT op-ed takes industry-friendly line, without disclosing author’s pharma ties

A recent op-ed published Monday in STAT insists that proposed FDA guidance for Alzheimer’s drug development is “good news” that “remov

STAT Plus: Pharma enlists a congressional ally to persuade U.S. trade officials to lean on Colombia

Pharma is doubling down on its campaign to force Colombia to alter its drug pricing and patent policies by enlisting the support of a congressional ally.

STAT Plus: Acadia Pharma raised the price of its only drug twice but quarterly sales still disappoint

A San Diego-based drug maker either didn’t receive — or is ignoring — pharma's new etiquette memo about easing back on egregious drug-price hikes, writes @adamfeuerstein

Drugs and Medications [268 Associated Drugs and Medications listed on BioPortfolio]

Topical hemo-stat [Henry Schein]


Stat-rinse [Triad Group]

Stat-Rinse 6605 Drug Facts and Label

Stat-foam [Triad Group]

Stat-Foam 6007 Drug Facts and Label

T-stat (erythromycin) 2.0% topical solution [Bristol-Myers Squibb Company]

T-Stat (erythromycin) 2.0% Topical Solution

Health stat [Triad Group]

Health Stat 6215 Drug Facts and Label

PubMed Articles [94 Associated PubMed Articles listed on BioPortfolio]

Nucleon Spin and Momentum Decomposition Using Lattice QCD Simulations.

We determine within lattice QCD the nucleon spin carried by valence and sea quarks and gluons. The calculation is performed using an ensemble of gauge configurations with two degenerate light quarks w...

χ_{c1} and χ_{c2} Resonance Parameters with the Decays χ_{c1,c2}→J/ψμ^{+}μ^{-}.

The decays χ_{c1}→J/ψμ^{+}μ^{-} and χ_{c2}→J/ψμ^{+}μ^{-} are observed and used to study the resonance parameters of the χ_{c1} and χ_{c2} mesons. The masses of these states are measured ...

Interleukin 17 regulates SHP-2 and IL-17RA/STAT-3 dependent Cyr61, IL-23 and GM-CSF expression and RANKL mediated osteoclastogenesis by fibroblast-like synoviocytes in rheumatoid arthritis.

Interleukin (IL)-17 predominately produced by the Th17 cells, plays a crucial role in the fibroblast-like synoviocytes (FLS) mediated disease process of rheumatoid arthritis (RA). IL-17 exerts its pat...

Delivering advanced therapies: The big pharma approach.

After two decades of focused development and some recent clinical successes, cell and gene therapy (CGT) is emerging as a promising approach to personalized medicines. Genetically engineered cells as ...

JAK and STAT members in channel catfish: Identification, phylogenetic analysis and expression profiling after Edwardsiella ictaluri infection.

The Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling pathway is one of the main pleiotropic cascades used to transmit information from extracellular receptors to th...

Clinical Trials [109 Associated Clinical Trials listed on BioPortfolio]

Blood Sparing Strategies: Omni-stat Routinary Use in Cardiac Surgery. A Prospective Randomized Study.

The study enrolles all consecutive patients undergoing cardiac surgery at the European Hospital, Rome. The population undergoes randomization to receive usual surgical hemostasis or added ...

Evaluation of the DPP HIV 1/2 Test and the HIV 1/2 Stat Pak Test Using Oral Fluid

This protocol is intended to test the feasibility of using the HIV 1/2 STAT-PAK and the DPP HIV 1/2 test (with and without the DPP Handheld Reader) to detect HIV antibodies in oral fluids.

STAT Inhibitor OPB-111077 and Decitabine in Treating Patients With Acute Myeloid Leukemia That Is Refractory or Newly Diagnosed and Ineligible for Intensive Chemotherapy

This phase I trial studies the side effects and best dose of STAT inhibitor OPB-111077 when given together with decitabine in treating patients with acute myeloid leukemia that does not re...

Oral Supplementation to Enhance Recovery Pilot Study - The MOTORS Trial

The goal of this clinical research study is to learn if the supplements Pro-Stat (which has l-arginine and also contains protein) and omega-3 fatty acids which can help inflammation and re...

A Pilot Preoperative Trial of Ganetespib With Paclitaxel for Triple-Negative Breast Cancer

Based on preclinical data implicating GR, AR, and JAK/STAT activation as potent mechanisms of breast cancer cell survival despite chemotherapy administration (i.e. chemotherapy resistance)...

Companies [759 Associated Companies listed on BioPortfolio]

Pharma Stat Sci

Welcome to Pharma Stat Sci, a work-in-progress. The purpose of this web is to provide information on leading pharmaceutical R&D data analysis technologies and methods.We will be providing a number of ...

AF Stat Working Group

AF Stat is a collaboration of healthcare leaders and organizations working to improve the health and well-being of people affected by atrial fibrillation. AF Stat is raising awareness of AFib as a co...

Stat-Tech Services

Stat-Tech Services most valuable asset is our people. Our senior staff cultivated their expertise at pharmaceutical companies and international Clinical Research Organizations. Stat-Tech Services prov...

Stat Health Services Inc.

Stat Health Services Inc. is an eHealth services company. Its STAT DOCTORS™ service provides members convenient and affordable online access to emergency medicine physicians ...

Rx Stat

Rx Stat is a pharmacy that specializes in the treatment of individuals. Unlike the Big-Box pharmacies of today's world, we work closely with the Physician and Patient, establishing a triad relationshi...

More Information about "Pharma Stat Sci" on BioPortfolio

We have published hundreds of Pharma Stat Sci news stories on BioPortfolio along with dozens of Pharma Stat Sci Clinical Trials and PubMed Articles about Pharma Stat Sci for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pharma Stat Sci Companies in our database. You can also find out about relevant Pharma Stat Sci Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record